Pathways To Bioreactor Process Scaling

Bioreactor scaling is the process of translating operating parameters from one bioreactor to another. It is required for cell culture biomanufacturing when advancing a molecule from process development (PD) to commercial manufacturing.
There is a growing market demand for novel molecules and biologics-based therapies beyond traditional monoclonal antibodies - including recombinant proteins, viral vectors, cell- and gene-based therapies, and others - and these advanced therapeutics often require changes to the level of production scale.
The bioreactor scaling process is complex and time-consuming. Digital scaling solutions can help reduce complexities associated with collecting, compiling, and sharing scaling data. Learn more about alternative scaling solutions in this eBook.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.